The New York-based startup Epibone intends to begin human testing on a procedure that will utilize stem cells to regenerate living bone tissue. The researchers, originally from Columbia University, will apply autologous [the patient’s own] stem cells to nanofiber scaffolding of the desired size and shape and direct the stem cells to differentiate into a physical and genetic replica of the patient’s own bone.
Current methods of bone replacement include autografting, synthetic implants, and grafting from a donor. However, grafting bone from the patient’s own body requires two painful and invasive surgeries, while grafting from a donor runs the risk of immune rejection. The application of autologous stem cells could one day produce bone tissue that can be implanted in only one surgery, without the risk of rejection, and, unlike a synthetic implant, will continue to grow with the patient over time. As stated by CEO Nina Tandon, “What we’re really proposing is a different view of the body, as a renewable resource of stem cells that can regenerate new parts as you need them.”
As personalized regenerative medicine advances, autologous stem cells will become an invaluable resource to families and individuals who seek to ensure that they will have access to the best in medical care should the need for it arise. One of the most convenient and affordable sources for recovering and banking your own stem cells is dental stem cells. To learn more about how to bank dental stem cells for use in future therapies and treatments, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now.™